Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Validation of models in patients with hepatocellular carcinoma
Xiaopeng Yan, Xu Fu, Chuang Cai, et al.
European Journal of Gastroenterology & Hepatology (2015) Vol. 27, Iss. 10, pp. 1180-1186
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment
Fabio Piscaglia, Sadahisa Ogasawara
Liver Cancer (2018) Vol. 7, Iss. 1, pp. 104-119
Open Access | Times Cited: 125
A Machine Learning Model to Predict Hepatocellular Carcinoma Response to Transcatheter Arterial Chemoembolization
Ali Morshid, Khaled M. Elsayes, Ahmed Khalaf, et al.
Radiology Artificial Intelligence (2019) Vol. 1, Iss. 5, pp. e180021-e180021
Open Access | Times Cited: 110
Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study
Jian‐Hong Zhong, Ning‐Fu Peng, Xue‐Mei You, et al.
Oncotarget (2017) Vol. 8, Iss. 11, pp. 18296-18302
Open Access | Times Cited: 69
Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial Therapy
Jae Ho Sohn, Rafael Durán, Yan Zhao, et al.
Clinical Gastroenterology and Hepatology (2016) Vol. 15, Iss. 5, pp. 746-755.e4
Open Access | Times Cited: 44
Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications
Alessandro Vitale, Fabio Farinati, Michele Finotti, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1673-1673
Open Access | Times Cited: 29
Advances in post-operative prognostic models for hepatocellular carcinoma
Ziqin He, Xiaomin She, Ziyu Liu, et al.
Journal of Zhejiang University SCIENCE B (2023) Vol. 24, Iss. 3, pp. 191-206
Open Access | Times Cited: 11
Cirrhotic patients and older people
Laura Bainy Rodrigues de Freitas, Larisse Longo, Deivid Cruz dos Santos, et al.
World Journal of Hepatology (2019) Vol. 11, Iss. 9, pp. 678-688
Open Access | Times Cited: 32
Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma
Tom Tan-To Cheung, Philip Chong‐hei Kwok, Stephen L. Chan, et al.
Liver Cancer (2018) Vol. 7, Iss. 1, pp. 40-54
Open Access | Times Cited: 32
<p>Novel Prognostic Nomograms for Predicting Early and Late Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy</p>
Wei Xu, Ruineng Li, Fei Liu
Cancer Management and Research (2020) Vol. Volume 12, pp. 1693-1712
Open Access | Times Cited: 25
Controversies and evidence of hepatic resection for hepatocellular carcinoma
Jian‐Hong Zhong, Guido Torzilli, Hao Xing, et al.
BBA Clinical (2016) Vol. 6, pp. 125-130
Open Access | Times Cited: 25
Validity of the Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for hepatocellular carcinoma in Singapore
Li Kim E. Selby, Rosanna X. Y. Tay, Winston Woon, et al.
Journal of Hepato-Biliary-Pancreatic Sciences (2016) Vol. 24, Iss. 3, pp. 143-152
Closed Access | Times Cited: 25
Simple models based on gamma-glutamyl transpeptidase and platelets for predicting survival in hepatitis B-associated hepatocellular carcinoma
Qing Pang, Jianbin Bi, Zhixin Wang, et al.
OncoTargets and Therapy (2016), pp. 2099-2099
Open Access | Times Cited: 24
Liver resection versus microwave ablation for hepatocellular carcinoma in ideal candidates for ablation per Barcelona Clinic Liver Cancer staging: a propensity score matching and inverse probability of treatment weighting analysis
Yao Tong, Ran Cai, Jun‐Xiang Li, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 11-12, pp. 1602-1614
Closed Access | Times Cited: 14
Validation of inflammation-based prognostic models in patients with hepatitis B-associated hepatocellular carcinoma: a retrospective observational study
Qing Pang, Lei Zhou, Kai Qu, et al.
European Journal of Gastroenterology & Hepatology (2017) Vol. 30, Iss. 1, pp. 60-70
Closed Access | Times Cited: 24
Barcelona Clinic Liver Cancer outperforms Hong Kong Liver Cancer staging of hepatocellular carcinoma in multiethnic Asians: Real-world perspective
James Weiquan Li, George Boon‐Bee Goh, Pik‐Eu Chang, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 22, pp. 4054-4054
Open Access | Times Cited: 20
HKLC Triages More Hepatocellular Carcinoma Patients to Curative Therapies Compared to BCLC and Is Associated with Better Survival
M. Christopher Wallace, Yi‐Hsiang Huang, David B. Preen, et al.
Digestive Diseases and Sciences (2017) Vol. 62, Iss. 8, pp. 2182-2192
Closed Access | Times Cited: 17
Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms
Young‐Sun Lee, Yeon Seok Seo, Ji Hoon Kim, et al.
Gut and Liver (2017) Vol. 12, Iss. 1, pp. 94-101
Open Access | Times Cited: 17
Impact of current staging systems on treatment strategy for HBV-related hepatocellular carcinoma
Xiaopeng Yan, Yudong Qiu
Cancer Letters (2015) Vol. 379, Iss. 2, pp. 220-224
Closed Access | Times Cited: 15
Hepatocellular carcinoma staging systems: Hong Kong liver cancer vs Barcelona clinic liver cancer in a Western population
Pablo Lozano, Maitane I. Orue-Echebarria, Lorena Martín, et al.
World Journal of Hepatology (2019) Vol. 11, Iss. 9, pp. 689-700
Open Access | Times Cited: 11
Infiltrative Hepatocellular Carcinoma
Xiaopeng Yan, Xu Fu, Min Deng, et al.
Medicine (2016) Vol. 95, Iss. 19, pp. e3589-e3589
Open Access | Times Cited: 8
The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021
Tan To Cheung, Simon C.H. Yu, Stephen L. Chan, et al.
HepatoBiliary Surgery and Nutrition (2022) Vol. 12, Iss. 3, pp. 366-385
Open Access | Times Cited: 6
BCLC-B Subclassification and the Hong Kong Liver Cancer System in Intermediate Hepatocellular Carcinoma
Larisse Longo, Laura Bainy Rodrigues de Freitas, Deivid Cruz dos Santos, et al.
American Journal of Clinical Oncology (2019) Vol. 42, Iss. 5, pp. 466-471
Closed Access | Times Cited: 6
Current HCC Staging Systems: Their Uses and Limitations
Yukio Tokumitsu, Hiroaki Nagano
Springer eBooks (2016), pp. 425-442
Closed Access | Times Cited: 4
A machine learning method for improving liver cancer staging
Zhengyun Zhao, Yichen Tian, Zheng Yuan, et al.
Journal of Biomedical Informatics (2022) Vol. 137, pp. 104266-104266
Open Access | Times Cited: 4
Prognostic Value of Circulating Tumour DNA in Asian Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Hongli Liu, Hong Yang, Xiaoliang Chen
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top